Current pharmacotherapeutical options for the prevention of kidney transplant rejection
Introduction: Advances in immunosuppression and medical care over the past years resulted in better short- and long-term graft survival following kidney transplantation. Novel potent immunosuppressive agents, combinations of proven substances and the steadily expanding knowledge on the pathophysiolo...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
08 Apr 2013
|
| In: |
Expert opinion on pharmacotherapy
Year: 2013, Jahrgang: 14, Heft: 8, Pages: 1029-1041 |
| ISSN: | 1744-7666 |
| DOI: | 10.1517/14656566.2013.788151 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1517/14656566.2013.788151
|
| Verfasserangaben: | Sebastian M Schaefer, MD, Caner Süsal, MD, Claudia Sommerer, Md, Martin Zeier, MD & Christian Morath |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1788331060 | ||
| 003 | DE-627 | ||
| 005 | 20220820121152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220202s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1517/14656566.2013.788151 |2 doi | |
| 035 | |a (DE-627)1788331060 | ||
| 035 | |a (DE-599)KXP1788331060 | ||
| 035 | |a (OCoLC)1341441184 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schäfer, Sebastian Markus |d 1985- |e VerfasserIn |0 (DE-588)1037798791 |0 (DE-627)756265444 |0 (DE-576)391831593 |4 aut | |
| 245 | 1 | 0 | |a Current pharmacotherapeutical options for the prevention of kidney transplant rejection |c Sebastian M Schaefer, MD, Caner Süsal, MD, Claudia Sommerer, Md, Martin Zeier, MD & Christian Morath |
| 264 | 1 | |c 08 Apr 2013 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.02.2022 | ||
| 520 | |a Introduction: Advances in immunosuppression and medical care over the past years resulted in better short- and long-term graft survival following kidney transplantation. Novel potent immunosuppressive agents, combinations of proven substances and the steadily expanding knowledge on the pathophysiology of kidney transplant rejection allows the extension of donor and recipient criteria, including the usage of organs from ABO-incompatible and crossmatch-positive donors, to overcome the increasing problem of organ shortage. Areas covered: Immunosuppressive regimens for the prevention of kidney transplant rejections with a focus on regimens aiming at calcineurin inhibitor or steroid minimization, withdrawal or avoidance. Prevention of antibody-mediated rejections in standard-risk and sensitized recipients, as well as newly introduced immunosuppressive substances are covered. Expert opinion: Currently applied immunosuppressive regimens are associated with excellent short-term graft survival. However, the long-term outcomes of different regimens substantially differ with regard to potential side effects, graft function, rejection and sensitization rates. The adverse effects of effective immunosuppression must carefully be balanced against the benefit, e.g., prevention of the development of donor-specific human leukocyte antigen antibodies and chronic (antibody-mediated) rejection. The choice of the appropriate immunosuppressive regimen requires clinical experience and careful consideration of recipient and transplant characteristics to achieve an optimal long-term graft survival. | ||
| 650 | 4 | |a antibody-mediated rejection | |
| 650 | 4 | |a calcineurin inhibitors | |
| 650 | 4 | |a high-risk sensitization | |
| 650 | 4 | |a immunosuppressive regimens | |
| 650 | 4 | |a kidney transplantation | |
| 700 | 1 | |a Süsal, Caner |e VerfasserIn |0 (DE-588)102648037X |0 (DE-627)726772763 |0 (DE-576)37182673X |4 aut | |
| 700 | 1 | |a Sommerer, Claudia |d 1971- |e VerfasserIn |0 (DE-588)121857654 |0 (DE-627)705680002 |0 (DE-576)292921829 |4 aut | |
| 700 | 1 | |a Zeier, Martin |e VerfasserIn |0 (DE-588)1026480302 |0 (DE-627)726772356 |0 (DE-576)371826438 |4 aut | |
| 700 | 1 | |a Morath, Christian |d 1973- |e VerfasserIn |0 (DE-588)124036155 |0 (DE-627)085595837 |0 (DE-576)293989923 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on pharmacotherapy |d Abingdon, Oxon : Routledge, Taylor & Francis, 1999 |g 14(2013), 8, Seite 1029-1041 |h Online-Ressource |w (DE-627)324741901 |w (DE-600)2030119-4 |w (DE-576)302969330 |x 1744-7666 |7 nnas |a Current pharmacotherapeutical options for the prevention of kidney transplant rejection |
| 773 | 1 | 8 | |g volume:14 |g year:2013 |g number:8 |g pages:1029-1041 |g extent:13 |a Current pharmacotherapeutical options for the prevention of kidney transplant rejection |
| 856 | 4 | 0 | |u https://doi.org/10.1517/14656566.2013.788151 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220202 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 124036155 |a Morath, Christian |m 124036155:Morath, Christian |d 50000 |e 50000PM124036155 |k 0/50000/ |p 5 |y j | ||
| 998 | |g 1026480302 |a Zeier, Martin |m 1026480302:Zeier, Martin |d 910000 |d 910100 |d 50000 |e 910000PZ1026480302 |e 910100PZ1026480302 |e 50000PZ1026480302 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 4 | ||
| 998 | |g 121857654 |a Sommerer, Claudia |m 121857654:Sommerer, Claudia |d 50000 |e 50000PS121857654 |k 0/50000/ |p 3 | ||
| 998 | |g 102648037X |a Süsal, Caner |m 102648037X:Süsal, Caner |d 910000 |d 911600 |d 50000 |e 910000PS102648037X |e 911600PS102648037X |e 50000PS102648037X |k 0/910000/ |k 1/910000/911600/ |k 0/50000/ |p 2 | ||
| 998 | |g 1037798791 |a Schäfer, Sebastian Markus |m 1037798791:Schäfer, Sebastian Markus |d 50000 |e 50000PS1037798791 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1788331060 |e 4049892103 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"13 S."}],"title":[{"title":"Current pharmacotherapeutical options for the prevention of kidney transplant rejection","title_sort":"Current pharmacotherapeutical options for the prevention of kidney transplant rejection"}],"person":[{"family":"Schäfer","given":"Sebastian Markus","role":"aut","display":"Schäfer, Sebastian Markus"},{"display":"Süsal, Caner","given":"Caner","role":"aut","family":"Süsal"},{"display":"Sommerer, Claudia","role":"aut","given":"Claudia","family":"Sommerer"},{"display":"Zeier, Martin","family":"Zeier","role":"aut","given":"Martin"},{"display":"Morath, Christian","family":"Morath","given":"Christian","role":"aut"}],"recId":"1788331060","name":{"displayForm":["Sebastian M Schaefer, MD, Caner Süsal, MD, Claudia Sommerer, Md, Martin Zeier, MD & Christian Morath"]},"origin":[{"dateIssuedDisp":"08 Apr 2013","dateIssuedKey":"2013"}],"id":{"eki":["1788331060"],"doi":["10.1517/14656566.2013.788151"]},"note":["Gesehen am 02.02.2022"],"relHost":[{"disp":"Current pharmacotherapeutical options for the prevention of kidney transplant rejectionExpert opinion on pharmacotherapy","recId":"324741901","part":{"volume":"14","pages":"1029-1041","text":"14(2013), 8, Seite 1029-1041","extent":"13","issue":"8","year":"2013"},"origin":[{"dateIssuedKey":"1999","publisher":"Routledge, Taylor & Francis ; Informa Healthcare","dateIssuedDisp":"1999-","publisherPlace":"Abingdon, Oxon ; London [u.a.]"}],"id":{"issn":["1744-7666"],"zdb":["2030119-4"],"eki":["324741901"]},"pubHistory":["1.1999/2000 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"EOP"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Expert opinion on pharmacotherapy","subtitle":"EOP","title":"Expert opinion on pharmacotherapy"}]}]} | ||
| SRT | |a SCHAEFERSECURRENTPHA0820 | ||